Imago BioSciences, Inc.

NasdaqGS:IMGO Voorraadrapport

Marktkapitalisatie: US$1.2b

Imago BioSciences Toekomstige groei

Future criteriumcontroles 0/6

Imago BioSciences is forecast to grow earnings and revenue by 14% and 77.7% per annum respectively while EPS is expected to grow by 23.5% per annum.

Belangrijke informatie

14.0%

Groei van de winst

23.5%

Groei van de winst per aandeel

Biotechs winstgroei27.1%
Inkomstengroei77.7%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Good

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Recent updates

Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans

Nov 08
Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans

Imago BioSciences GAAP EPS of -$0.41 beats by $0.09

Aug 12

Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation

Jul 26
Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation

Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth

Apr 12
Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth

We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate

Dec 08
We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate

Winst- en omzetgroeiprognoses

NasdaqGS:IMGO - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202511-122-115-925
12/31/2024N/A-111-90-1105
12/31/2023N/A-88-73-836
12/31/2022N/A-65-60N/A6
9/30/2022N/A-62-52-52N/A
6/30/2022N/A-57-53-53N/A
3/31/2022N/A-52-44-44N/A
12/31/2021N/A-42-40-40N/A
9/30/2021N/A-33-31-31N/A
6/30/2021N/A-26-24-24N/A
3/31/2021N/A-21-20-20N/A
12/31/2020N/A-18-17-17N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: IMGO is forecast to remain unprofitable over the next 3 years.

Winst versus markt: IMGO is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: IMGO is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: IMGO is forecast to have no revenue next year.

Hoge groei-inkomsten: IMGO is forecast to have no revenue next year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if IMGO's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven